Rock Springs Capital Management LP Q3 2019 Filing
Filed November 14, 2019
Portfolio Value
$2.5T
Holdings
138
Report Date
Q3 2019
Filing Type
13F-HR
All Holdings (138 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | —MOMENTA PHARMACEUTICALS INC | 400,000 | $5.2B | 0.21% | |
| 102 | AKROAKERO THERAPEUTICS INC | 225,000 | $5.1B | 0.20% | |
| 103 | INSM 1.75 01/15/25INSMED INC | 6,000,000 | $5.0B | 0.20% | |
| 104 | —DERMIRA INC | 775,000 | $5.0B | 0.20% | |
| 105 | NGMUSDNGM BIOPHARMACEUTICALS INC | 351,100 | $4.9B | 0.19% | |
| 106 | CGENCOMPUGEN LTD | 1,100,000 | $4.7B | 0.19% | |
| 107 | CBAYUSDCYMABAY THERAPEUTICS INC | 900,000 | $4.6B | 0.18% | |
| 108 | —NABRIVA THERAPEUTICS PLC | 2,300,000 | $4.6B | 0.18% | |
| 109 | —MEDICINES CO | 3,000,000 | $4.5B | 0.18% | |
| 110 | —GLOBAL CORD BLOOD CORPORATIO | 925,000 | $4.5B | 0.18% | |
| 111 | —CHIASMA INC | 900,000 | $4.5B | 0.18% | |
| 112 | —GAMIDA CELL LTD | 1,000,000 | $4.3B | 0.17% | |
| 113 | —BLUEBIRD BIO INC | 47,000 | $4.3B | 0.17% | |
| 114 | HCATHEALTH CATALYST INC | 125,000 | $4.0B | 0.16% | |
| 115 | MGNXMACROGENICS INC | 300,000 | $3.8B | 0.15% | |
| 116 | —LA JOLLA PHARMACEUTICAL CO | 425,000 | $3.7B | 0.15% | |
| 117 | ICPTUSDINTERCEPT PHARMACEUTICALS IN | 54,400 | $3.6B | 0.14% | |
| 118 | —RESTORBIO INC | 400,000 | $3.5B | 0.14% | |
| 119 | ARVNARVINAS INC | 150,000 | $3.2B | 0.13% | |
| 120 | ACRSACLARIS THERAPEUTICS INC | 2,974,754 | $3.2B | 0.13% | |
| 121 | TXG10X GENOMICS INC | 63,500 | $3.2B | 0.13% | |
| 122 | —FIVE PRIME THERAPEUTICS INC | 775,000 | $3.0B | 0.12% | |
| 123 | —CORREVIO PHARMA CORP | 1,200,000 | $2.4B | 0.10% | |
| 124 | —MYOVANT SCIENCES LTD | 450,000 | $2.3B | 0.09% | |
| 125 | —MERSANA THERAPEUTICS INC | 1,400,000 | $2.2B | 0.09% | |
| 126 | —PARATEK PHARMACEUTICALS INC | 450,000 | $1.9B | 0.08% | |
| 127 | —THERAVANCE BIOPHARMA INC | 1,500,000 | $1.4B | 0.05% | |
| 128 | NBIX 2.25 05/15/24NEUROCRINE BIOSCIENCES INC | 1,000,000 | $1.4B | 0.05% | |
| 129 | —RADIUS HEALTH INC | 1,500,000 | $1.4B | 0.05% | |
| 130 | ADAPYADAPTIMMUNE THERAPEUTICS PLC | 875,000 | $1.3B | 0.05% | |
| 131 | CRVSCORVUS PHARMACEUTICALS INC | 400,000 | $1.2B | 0.05% | |
| 132 | CLVSEURCLOVIS ONCOLOGY INC | 256,000 | $1.0B | 0.04% | |
| 133 | —PACIRA BIOSCIENCES | 1,000,000 | $988.0M | 0.04% | |
| 134 | —DERMIRA INC | 1,000,000 | $844.0M | 0.03% | |
| 135 | NVV1NOVAVAX INC | 162,500 | $816.0M | 0.03% | |
| 136 | KLDOKALEIDO BIOSCIENCES INC | 100,050 | $753.0M | 0.03% | |
| 137 | —PROTEOSTASIS THERAPEUTICS IN | 400,000 | $338.0M | 0.01% | |
| 138 | CVETUSDCOVETRUS INC | 20,683 | $246.0M | 0.01% |
PreviousPage 2 of 2